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Abstract
Background: In previous studies on an Iberian x Landrace cross, we have provided evidence that supported the
porcine ELOVL6 gene as the major causative gene of the QTL on pig chromosome 8 for palmitic and palmitoleic
acid contents in muscle and backfat. The single nucleotide polymorphism (SNP) ELOVL6:c.-533C > T located in the
promoter region of ELOVL6 was found to be highly associated with ELOVL6 expression and, accordingly, with the
percentages of palmitic and palmitoleic acids in longissimus dorsi and adipose tissue. The main goal of the current
work was to further study the role of ELOVL6 on these traits by analyzing the regulation of the expression of ELOVL6
and the implication of ELOVL6 polymorphisms on meat quality traits in pigs.
Results: High-throughput sequencing of BAC clones that contain the porcine ELOVL6 gene coupled to RNAseq
data re-analysis showed that two isoforms of this gene are expressed in liver and adipose tissue and that they differ
in number of exons and 3’UTR length. Although several SNPs in the 3’UTR of ELOVL6 were associated with palmitic
and palmitoleic acid contents, this association was lower than that previously observed with SNP ELOVL6:c.-533C > T.
This SNP is in full linkage disequilibrium with SNP ELOVL6:c.-394G > A that was identified in the binding site for
estrogen receptor alpha (ERα). Interestingly, the ELOVL6:c.-394G allele is associated with an increase in methylation
levels of the ELOVL6 promoter and with a decrease of ELOVL6 expression. Therefore, ERα is clearly a good candidate
to explain the regulation of ELOVL6 expression through dynamic epigenetic changes in the binding site of known
regulators of ELOVL6 gene, such as SREBF1 and SP1.
Conclusions: Our results strongly suggest the ELOVL6:c.-394G > A polymorphism as the causal mutation for the QTL
on pig chromosome 8 that affects fatty acid composition in pigs.
Background
Elongation of very long-chain fatty acids proteins
(ELOVL) are a family of enzymes that catalyze the initial
and rate-limiting condensation reaction of fatty acid
elongation cycle in mammals [1-3]. To date, seven ELOVL
proteins have been identified i.e. ELOVL1, ELOVL3,
ELOVL6 and ELOVL7 that act preferentially on saturated
fatty acids (SFA) and monounsaturated fatty acids
(MUFA) and ELOVL2, ELOVL4 and ELOVL5 that act
preferentially on polyunsaturated fatty acids (PUFA) [4-6].
In mammals, the enzyme ELOVL6 catalyzes the elong-
ation of long-chain SFA and MUFA with 12 to 18 carbon
atoms and is considered as a key gene in the control of
the overall balance of fatty acid composition [2,7]. Expres-
sion of the gene coding for ELOVL6 is highly up-
regulated, both in liver and adipose tissue in the refed
state compared to fasting state, which indicates that this
enzyme has a major role in the synthesis of long-chain
fatty acids [8].The porcine ELOVL6 gene is located on
chromosome 8 (SSC8, SSC for Sus scrofa), in a region
where a quantitative trait locus (QTL) that affects palmitic
and palmitoleic acid contents was previously detected
[2,9]. Moreover, it was recently reported that this gene is
differentially expressed in adipose tissue from Iberian x
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Landrace backcross animals with extreme phenotypic dif-
ferences in intramuscular fatty acid composition [10].
Expression of ELOVL6 was first identified in the liver
of transgenic mice that over-expressed sterol regulatory
element binding transcription factors (SREBF) [1]. SREBF
are transcription factors that control the expression of
genes involved in de novo lipogenesis [11]. In tissues that
synthesize fatty acids de novo, expression of SREBF is
highly correlated with that of key lipogenic genes involved
in this metabolic pathway [12]. Transcriptional regulation
of ELOVL6 by SREBF was also confirmed by using DNA
microarrays to analyze the expression of ELOVL6 in trans-
genic mice overexpressing SREBF1. [13], and by analyzing
the promoter region of mouse ELOVL6 [14]. Kumadaki
et al. [14] demonstrated that in mouse liver, nuclear
SREBF1 activates the ELOVL6 promoter by interacting
with two sterol response elements (SRE). However, al-
though SREBF1 can bind to E-box motifs, there was no
evidence that E-box motifs were involved in ELOVL6 ac-
tivity [14,15]. Results of our previous analysis on the pro-
moter of pig ELOVL6 [2] showed that: (1) pig and mouse
ELOVL6 promoters share SRE and E-box motifs, and in
the pig ELOVL6 promoter, SRE elements are present at
positions −18, −450 and −524 and an E-box motif at pos-
ition −331; (2) a single nucleotide polymorphism (SNP)
i.e. ELOVL6:c.-533C > T is located close to the most distal
SRE element and is highly associated with percentages of
palmitic and palmitoleic acids in muscle and backfat and
with the expression level of ELOVL6 in backfat; (3) the pig
ELOVL6 promoter contains binding sites for other tran-
scription factors i.e. for SP1 transcription factor (SP1) at
position −470 with a SNP at position −480 i.e. ELOVL6:c.-
480C > T and for MLX interacting protein-like (MLXIPL)
at position −322 (also called carbohydrate response elem-
ent binding protein or ChREBP); (4) the pig ELOVL6 pro-
moter contains five additional SNPs (ELOVL6:c.-574C > T,
ELOVL6:c.-534C > T, ELOVL6:c.-492G > A, ELOVL6:c.-
394G > A and ELOVL6:c.-313C > T); and (5) expression of
ELOVL6 varies between various lipogenic tissues (liver,
adipose tissue and muscle), which suggests that the mech-
anisms that regulate the expression of this gene differ in
each tissue. In addition, we performed a whole-genome
association study of the expression levels of ELOVL6
(eGWAS) in liver, adipose tissue and muscle and identified
several genomic regions that may be involved in the
tissue-specific expression of this gene [2]. Epigenetic mod-
ifications is another mechanism that can contribute to
these tissue-specific differences in the expression of
ELOVL6 [16]. DNA methylation is one of the major epi-
genetic mechanisms that regulates gene transcription and
it was shown to be involved in the regulation of genes as-
sociated to lipid metabolism, such as fatty acid desaturase
2 (FADS2) [17] or peroxisomal proliferator-activated re-
ceptor alpha (PPARα) [18]. Finally, one cannot exclude
the possibility that microRNAs, a class of short non-
coding RNAs with a key role in gene expression, may
affect expression of ELOVL6, since the 3’UTR of porcine
ELOVL6 gene has not been fully characterized.
The overall objective of the present study was to inves-
tigate the mechanisms that contribute to the control and
regulation of ELOVL6 expression and their influence on
porcine meat quality traits. Thus, we characterized the
3’UTR of porcine ELOVL6 and identified several poly-
morphisms. In addition, we performed a methylation
study of the ELOVL6 promoter region on DNA ex-
tracted from liver, adipose tissue, muscle and spleen, to
determine whether epigenetic modifications play a role
in the differential expression of ELOVL6 across tissues.
Methods
Animals
The population analyzed was generated by crossing
three Iberian (Guadyerbas line) boars with 31 Landrace
sows (the so-called IBMAP cross) [19], and contained
several generations and backcrosses. The animals used
in this study belonged to the backcross (BC1_LD) that
was produced by crossing five F1 (Iberian x Landrace)
boars with 26 Landrace sows and resulted in 144 back-
crossed animals. All pigs were raised and fed under the
standard intensive system in Europe and feeding was ad
libitum with a cereal-based commercial diet. Pigs were
slaughtered at an average age of 179.8 ± 2.6 days follow-
ing national and institutional guidelines for the Good
Experimental Practices and approved by the Ethical
Committee of the Institution (IRTA- Institut de Recerca
i Tecnologia Agroalimentàries). Samples of liver, muscle
(longissimus dorsi) and adipose tissue (backfat) were col-
lected, snap-frozen in liquid nitrogen and stored at −80°C.
Genomic DNA was obtained from blood and liver
samples from the 144 animals according to the phenol-
chloroform method, as described elsewhere. Backfat [20]
and intramuscular fatty acid composition [9] was mea-
sured with a protocol based on gas chromatography of
methyl esters [21].
BAC screening and sequencing
The porcine bacterial artificial chromosome (BAC)
INRA library (Centre de Ressources Biologiques Géno-
mique des Animaux Domestiques et d’Intérêt Economi-
que i.e. CRB-GADIE; http://crb-gadie.inra.fr) was used
to select BAC clones containing the SSC8 region that
carries ELOVL6. This BAC library constructed with the
pBeloBAC11 vector comprises 107 520 clones with an
average insert size of 135 kb, representing a five-fold
coverage of the pig haploid genome [22]. Screening of
the library was performed using three sets of primers lo-
cated respectively in the promoter region, second exon
(intermediate gene region) and at the end of the coding
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region in exon 4, in order to encompass the major part
of ELOVL6 gene (See Additional file 1: Table S1).
Primers were designed using the software PRIMER3 [23]
and validated using the software PRIMER EXPRESSTM
(Applied Biosystems). BAC screening was performed by
two-step PCR according to CRB-GADIE protocols (PCR
of superpools and pools) and positive BAC clones were
confirmed by checking the size of their PCR-amplified
fragments.
BAC clones were cultured on Luria-Bertani (LB) agar
containing 12.5 μg/mL of chloramphenicol overnight at
37 °C and then, isolated clones were grown in 4 ml LB
broth with 12.5 μg/mL of chloramphenicol overnight at
37 °C in a shaking incubator. Finally, 4 mL of the over-
night starter culture was inoculated in 500 ml LB-
medium supplemented with chloramphenicol (12.5 μg/mL)
and incubated in the same conditions to an optical
density of 2. BAC DNA was isolated using the plasmid
DNA purification Nucleobond BAC100 kit (Macherey-
Nagel), following the manufacturer’s recommendations
of the low-copy plasmid purification (Maxi BAC100)
section. DNA was quantified using the Nano-Drop
ND-1000 spectrophotometer (NanoDrop products)
and checked for purity and integrity by electrophoresis
on agarose gels.
For each BAC, bar-coded libraries were generated using
the Ion Xpress Plus fragment library kit (Life Technologies)
with an insert size of approximately 250 bp. Libraries were
sequenced on a Personal Genome Machine (PGM) Ion
Torrent instrument (Life Technologies) using an Ion 314R
chip. More than 220 000 single-end reads were generated
with an average read length of 152 bp for each library.
De novo assembly and characterization of the porcine
ELOVL6 gene
Statistics of reads and quality control were determined
with FASTQC [http://www.bioinformatics.babraham.ac.
uk/projects/fastqc/]. All reads were mapped against the
Escherichia coli genome using the Burrows-Wheeler
Alignment tool (bwa v.0.6.2) [24], in order to discard all
reads corresponding to bacterial DNA. Removal of se-
quence adapters, quality trimming of reads and de novo
assembly were performed using the de novo assembler
tool of CLC Genomics Workbench v.6.0.1 [http://www.
clcbio.com]. The 3’UTR sequence of ELOVL6 was iden-
tified from de novo assembled reads aligned with the
corresponding human (GenBank:NM_001130721) and
bovine (GenBank:NM_001102155) genes, using the
Basic Local Alignment Search Tool (BLAST v2.2.28)
[25]. The resulting pig ELOVL6 3’UTR sequence was
used as reference sequence to align reads from liver (12
BC1_LD animals) and adipose tissue (6 BC1_LD animal)
transcriptomes that were obtained in previous studies
[10,26] by using the software TopHat v2.0.1 [27,28] and
including the pig genome (Sscrofa10.2) [http://www.
ensembl.org/info/data/ftp/index.html] as a combined
reference. Finally, SNPs in the ELOVL6 gene were manu-
ally identified by comparing the reference sequence with
mapped reads with the Integrative Genomic Viewer (IGV
v.2.1) [29,30].
Genotyping
SNPs ELOVL6:c.1408C > T and ELOVL6:c.1922C > T
were genotyped using the platform KASP SNP geno-
typing system [http://www.lgcgroup.com/products/kasp-
genotyping-chemistry/#.VQAP4fmG9ak]. A total of 179
animals including the 144 BC1_LD backcross animals and
their corresponding 35 parents from the IBMAP cross
(F0 and F1) were genotyped.
For the genome-wide association study (GWAS), the
144 animals of the BC1_LD backcross were genotyped
with the Porcine SNP60 Illumina BeadChip using the
Infinium HD Assay Ultra protocol (Illumina). Raw data
had a high genotyping quality (call rate > 0.99) and were
visualized and analyzed with the Illumina GenomeStudio
software. For subsequent data analysis, a subset of 54
998 SNPs was selected by removing SNPs with a minor
allele frequency less than 5%, SNPs with more than 5%
missing genotype data and SNPs that were duplicated in
the Sscrofa10.2 assembly.
Chromosome-wide association analyses
Association analyses of whole-genome SNP genotypes,
together with the previously identified SNPs ELOVL6:c.-
533C > T, ELOVL6:c.-480C > T, ELOVL6:c.416C > T [2]
and the newly detected ELOVL6:c.1408A >G and ELOVL6:
c.1922C >T SNPs were performed on the following pheno-
types: RT-qPCR expression data of ELOVL6 mRNA in
backfat and C16:0 and C16:1(n-7) fatty acids composition
in backfat and intramuscular fat. The position of the SNPs
was based on the Sscrofa10.2 genome assembly [http://
www.animalgenome.org/repository/pig/]. GWAS were per-
formed with a mixed model [31,32] that accounted for
additive effects associated with each marker (see below)
by using the Qxpak 5.0 software [33]:
yijlkm ¼ Sexi þ Batchj þ λlak þ ul þ eijlkm;
in which yijlkm is the l-th individual’s record, sex (two
levels) and batch (five levels) are fixed effects, λl is a −1,
0, +1 indicator variable depending on the l-th individ-
ual’s genotype for the k-th SNP, ak represents the addi-
tive effect associated with the k-th SNP, ul represents the
polygenic effect for individual l, treated as random and
distributed as N(0, Aσu), where A is the numerator of
the kinship matrix, and eijlkm is the residual. The poly-
genic effect allows us to account for family relationships.
In this analysis, each SNP was tested individually for
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association with phenotype. The R package q-value
[34] was used to calculate the FDR-based q-value to
measure the statistical significance at the genome-
wide level for association studies. The cut-off for a
significant association at the chromosome level was
set at a q-value ≤ 0.05. In addition, carcass weight (βcl)
was added to the model as a covariate for fatty acid
composition:
yijlkm ¼ Sexi þ Batchj þ βcl þ λlak þ ul þ eijlkm:
The same model was used to determine the effect of
haplotypes on the traits of interest. The only difference
is that haplotypes were treated as random additive ef-
fects, in contrast to the individual SNPs, which were
considered as fixed additive effects.
DNA methylation analyses
DNA methylation analyses of liver and backfat were
performed on 43 animals, while muscle and spleen
that were chosen as control tissues expressing low
levels of ELOVL6 were analyzed on six animals. DNA
was extracted using the phenol-chloroform method, as
described elsewhere. Methylation studies were per-
formed using the bisulfite methodology [35] and the
pyrosequencing technique [36,37]. The bisulfite gDNA
conversion was performed on 500 ng of genomic
DNA from each sample with the EZ DNA Methylation
kit (Zymo Research). The regions of interest were
amplified using primers (See Additional file 1: Table
S1) that were designed from the resulting methylated
sequence using the allele quantification assay type of
the PSQ assay design software (Biotage). PCR were
performed in 25 μL samples containing 0.6 units of
AmpliTaq Gold (Applied Biosystems), 1.5 to 2.5 mM
MgCl2 (depending on the primers; (See Additional file 1:
Table S1)), 0.2 mM of each dNTP, 0.5 μM of each pri-
mer and 25 ng of treated genomic DNA. PCR were car-
ried out under the following conditions: 94°C for
10 min, 40 cycles of 94°C for 1 min, 60°C for 1 min and
72°C for 1 min, with a final extension at 72°C for
7 min. Pyrosequencing analysis was carried out on a
PSQ HS 96A system with the Pyro Gold sequence ana-
lysis (SQA) reagent (Biotage) using specific pyrose-
quencing primers for each region (See Additional file 1:
Table S1). Statistical comparison of methylation values
between tissues, genotypes and gene expression data
was made using an ANOVA test in R considering sex
and batch. RNA extraction, cDNA synthesis and gene
expression analysis by real time quantitative PCR (RT-
qPCR) were performed following the procedure de-
scribed in [2].
Results and discussion
Pig ELOVL6 gene structure and identification of a new
isoform
Despite the important role played by ELOVL6 in lipid
metabolism [2,3,7], a comparison of human, bovine and
porcine ELOVL6 mRNA sequences revealed that the
current sequence of the porcine ELOVL6 gene is incom-
plete (data not shown). In order to characterize pig
ELOVL6, we screened a pig BAC library for its promoter
region, exon 2 (intermediate region) and exon 4 (ter-
minal region). Six BAC clones that contain at least one
of these three regions were identified by PCR: BAC
651E12, 650D01 and 385A04 were positive for the pro-
moter region, BAC 201D05, 95C02, 754E02 and 385A04
were positive for exon 2 and BAC 754E02 was positive
for exon 4. Of these six BAC clones, only BAC 385A04
and 754E02 were positive for two different sequences, i.
e. BAC 385A04 contained the promoter and exon 2 re-
gions and BAC 754E02 contained exons 2 and 4, which
suggests that these two clones cover most of the porcine
ELOVL6 gene. DNA of both BAC clones was sequenced
with the PGM of Ion Torrent and around 265 000
single-end reads were generated for each BAC with an
average read length of 152 bp. The data generated was
used to perform a de novo assembly of porcine ELOVL6
with the CLC Genomics Workbench v.6.0.1. The 129
672 bp long sequence contained 1942 bp of the up-
stream region, four introns and five exons of porcine
ELOVL6 (Figure 1). The protein coding region starts at
position 2201 bp and ends at position 123 132 bp of this
sequence (Figure 1). To validate the new gene annota-
tion, RNA-Seq data from adipose tissue and liver tran-
scriptomes [10,26] were used to map the reads against
the new ELOVL6 sequence. The alignments obtained
were concordant with the proposed ELOVL6 gene struc-
ture, but some reads were located between the first and
second exons. In addition, the number of mapped reads
was clearly reduced in the middle of the fifth exon.
Interestingly, a poly-A signal was identified in this region
(at position 124 578 bp), which indicates the end of an
alternative isoform (Figure 1). Therefore, as for the hu-
man ELOVL6 gene, two different isoforms of porcine
ELOVL6 are expressed in both liver and adipose tissue.
These isoforms differ in: (i) total number of exons, i.e. four
in variant 2 (the first and second exons are combined into
a single exon) against five in variant 1, and (ii) length of
the 3’UTR, which is shorter in variant 2 (1455 bp) than in
variant 1 (5117 bp) (Figure 1).
Identification of polymorphisms in the 3’UTR of porcine
ELOVL6
Alignment and analysis of all mapped reads from RNA-
Seq data [10,26] allowed us to identify 11 SNPs (Table 1)
in the 3’UTR of porcine ELOVL6, among which five
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were found in both variants and six were found only in
variant 2. All SNPs were arranged in three haplotypes,
which can be distinguished by genotyping ELOVL6:
c.1408A > G and ELOVL6:c.1922A > G SNPs. Hence,
these two tag SNPs were genotyped in IBMAP founders,
parental BC1_LD animals and the BC1_LD population.
Regarding the IBMAP founders, alleles ELOVL6:c.1408G
and ELOVL6:c.1922G were fixed in Iberian boars. The
ELOVL6:c.1408A allele was fixed in the founder Land-
race sows, whereas the allele ELOVL6:c.1922A had a fre-
quency of 0.7 in these sows. In BC1_LD Landrace sows,
allelic frequencies of ELOVL6:c.1408A and ELOVL6:
c.1922A were 0.94 and 0.38, respectively. Both ELOVL6:
c.1408A > G and ELOVL6:c.1922A > G SNPs segregated
in the BC1_LD animals with frequencies for allele A
equal to 0.72 and 0.46, respectively.
It is well known that the presence of polymorphisms
in the 3’UTR of genes may affect the binding of micro-
RNAs. This interaction is important for the regulation
of gene expression, since microRNAs mediate transla-
tional repression and mRNA destabilization [38]. For
instance, microRNA miR-33a/b has been described as
a potential regulator of lipid metabolism by repressing
the translation of genes coding for key enzymes that
are involved in cholesterol efflux (ABCA1 and NPC1),
fatty acid metabolism (CROT and CPT1a) and insulin
signaling (IRS2) [39,40]. To assess if the polymor-
phisms present in the 3’UTR of ELOVL6 affect the dis-
ruption or creation of microRNA binding sites, a
computer-assisted identification of potential micro-
RNA binding elements was performed using the finder
tool of patrocles programme [41]. Twelve putative
microRNA binding sites were found to be modified by
the 11 detected SNPs. MicroRNAs miR-524-3p, miR-
525-3p, miR-18a/b, miR-204 and miR-211 were predicted
to bind to both mRNA isoforms, whereas miR-584, miR-
452, miR-603, miR-1262, miR-490-5p, miR-30a/d/e and
miR-335 were predicted to bind only to variant 2. These
predictions suggest that microRNAs may be involved in
the regulation of porcine ELOVL6. However, further
studies are needed to elucidate their role in the differen-
tial expression of ELOVL6 in pig adipose tissue, liver
and muscle.
Figure 1 Genetic architecture of the porcine ELOVL6 gene, with the two transcribed variants identified by BAC sequencing and
RNAseq analysis. Exons are indicated by blue boxes with dark blue corresponding to sequences that code for ELOVL6 protein and pale blue to
5’UTR and 3’UTR regions.
Table 1 Polymorphisms identified in the 3’UTR of the
ELOVL6 gene
Position (bp)1 Polymorphism Isoform
14082 A/G Variant 1 and 2
1817 C/T
19222 A/G
2070 C/G
2532 A/G
3599 G/T Variant 2
3834 A/G
4750 A/G
4765 G/T
4967 A/C
5233 A/C
1Positions relative to the transcription start site, TSS, of the GenBank:
NW_003610943; 2SNPs genotyped in the BC1_LD population.
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Association studies support the major role of the ELOVL6:
c.-533C > T polymorphism
Previously, we found that SNP ELOVL6:c.-533C > T in
the promoter region of ELOVL6 was associated with a
QTL on SSC8 that affects palmitic and palmitoleic acid
contents in muscle and backfat [2]. This SNP explained
a large part of the phenotypic variance of each of these
traits in both BF and IMF tissues: 18% for C16IMF, 32%
for C16BF, 20% for C16:1(n-7)IMF and 19% for C16:1(n-7)
GD. Nevertheless, we cannot exclude that other SNPs
may also have a major association with these traits. The
two newly genotyped 3’UTR SNPs and the three SNPs
previously described in [2] were added to the 2565 SNPs
on SSC8 that are included in the Porcine Illumina
SNP60 BeadChip, in order to perform association ana-
lyses on 136 BC1_LD animals for FA composition in
muscle and backfat. In this analysis, SNP ELOVL6:
c.1922A > G showed a significant association with the per-
centages of palmitic acid in muscle (p-value = 3.38×10−04)
and backfat (p-value = 1.23x10−11) (Figure 2A and C). In
contrast, SNP ELOVL6:c.1408A >G showed significant as-
sociations only with percentage of palmitic acid in backfat
(p-value = 1.73x10−06) (Figure 2C). In addition, percentage
of palmitoleic acid was significantly associated with SNP
ELOVL6:c.1922A >G in both muscle (p-value = 1.51×10−07)
and backfat (p-value = 1.22x10−06) (Figure 2B and D). Sig-
nificant associations were also found between palmitoleic
acid and SNP ELOVL6:c.1408A >G in muscle (p-value =
4.86×10−05) and backfat (p-value = 4.24×10−04) (Figure 2B
and D). The effect of the haplotypes formed by the com-
bination of these two SNPs (ELOVL6:c.1408A >G and
ELOVL6:c.1922A >G) on the different traits was tested,
but no significant associations were observed (data not
shown). Nevertheless, for both FA, SNP ELOVL6:c.-533C
> T always showed a greater association than the 3’UTR
SNPs (Figure 2), which further supports its role in the de-
termination of the SSC8 QTL. No significant associations
were observed between the SNPs in the 3’UTR sequence
and ELOVL6 expression levels in backfat, liver and muscle
(data not shown).
Taken together, these results indicate that SNP ELOVL6:
c.-533C > T in the promoter of ELOVL6 is the most prom-
ising candidate among the genotyped SNPs on SSC8.
However, to further support the main role of this SNP, an
association study was performed to compare the individ-
ual effect of SNPs ELOVL6:c.-533C > T and ELOVL6:
c.1922A > G against the effect of the haplotypes formed by
the combination of these two SNPs. These analyses were
performed with a reduced number of animals (n = 94),
for which the allele origin (Iberian or Landrace) could
be unambiguously determined based on pedigree infor-
mation. As expected, the effect of SNP ELOVL6:c.-
533C > T was greater than that of the haplotypes for all
analyzed traits (p-value backfat gene expression = 3.68×10
−03,
p-value IMF_C16:0 = 1.33×10
−03, p-value IMF_C16:1(n-7) =
3.72×10−04, p-value BF_C16:0 = 6.15×10
−10 and p-value
BF_C16:1(n-7) = 9.15×10
−04) (See Additional file 2: Table
S2). In conclusion, our results confirm that SNP
ELOVL6:c.-533C > T plays a key role in explaining the
SSC8 QTL that affects palmitic and palmitoleic acid
contents in pig. However, we cannot exclude the possi-
bility that the 3’UTR may have a secondary role on the
regulation of ELOVL6 expression or that other variants
located in intronic regions may be involved.
Promoter methylation is an additional level in the
regulation of porcine ELOVL6 expression
DNA bisulfite conversion was used to compare the methy-
lation patterns of the promoter region of pig ELOVL6 be-
tween liver, adipose tissue (backfat), muscle and spleen
(tissues with low levels of ELOVL6 expression). The
methylation study was focused on CpG-sites whose meth-
ylated states may affect the binding of SREBF1, the most
relevant transcription factor of ELOVL6. All individual
CpG-sites identified in the SRE and E-box motifs of
ELOVL6 promoter [2] were included in the study. In
addition, it was observed that SP1 is required as an add-
itional regulator for SREBF1 activity in several lipogenic
genes [1,42]. Interestingly, a CpG-site was identified in the
SP1 binding element, in which SNP ELOVL6:c-416C > T
[2] is located (Figure 3A), making this CpG a clear candi-
date. Finally, six CpG sites, that covered the major part of
the described promoter, were analyzed (Figure 3A).
Methylation analysis of these CpG sites showed that
methylation levels were higher in muscle and spleen than
in liver and adipose tissue (Figure 3B). These results are in
agreement with the lower level of ELOVL6 expression ob-
served in the former tissues (Figure 4), which suggests that
an epigenetic mechanism may be involved in the regula-
tion of ELOVL6 mRNA abundance.
The six selected CpG sites were distributed in two
clear regions with opposite levels of methylation i.e. (i)
lower methylation levels in the proximal region
(−349 bp to −1 bp) and (ii) higher methylation levels in
the distal region (−529 bp to -350 bp) (Figure 3B). On
the one hand, the low methylation levels in the proximal
region (CpG1, CpG2 and CpG3) in all tissues, suggest
that this region may be important for maintaining a
basal gene expression. On the other hand, the higher
methylation levels in the distal promoter regions (CpG4,
CpG5 and CpG6), suggest that methylation of these motifs
may be relevant for the regulation of ELOVL6 expression
among tissues. Statistical analyses showed significant lower
methylation levels of these sites in liver than in backfat
(p-value CpG4 = 7.27×10−09, p-value CpG5 = 1.18×10−05
and p-value CpG6 = 1.04×10−07), muscle (p-value CpG4 =
2.13×10−14, p-value CpG5 = 1.52×10−10 and p-value
CpG6= 1.82×10−14) and spleen (p-value CpG4= 4.42×10−11,
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p-value CpG5= 5.24×10−07 and p-value CpG6= 1.47x10−10)
(Figure 3B). Methylation levels in adipose tissue were clearly
higher than in liver, although expression of ELOVL6 is
higher in adipose tissue than in liver [2]. The higher levels
of ELOVL6 expression in adipose tissue are explained by
the major role of this tissue in lipogenic pathways in pigs
[43,44] and, consequently, lipogenic genes are upregulated
by SREBF1 in this tissue [43]. In agreement, gene expres-
sion correlation analysis performed in our animal material,
showed a high correlation between SREBF1 and ELOVL6
(r = 0.77) in adipose tissue, but not in liver (Ballester et al.,
unpublished). Thus, these results allowed us to
hypothesize that methylation of the ELOVL6 promoter
region between −529 bp and −350 bp may be one pos-
sible mechanism responsible for the differential ex-
pression of this gene among the tissues analyzed. This
region contains one methylated SRE element and one
SP1 binding site, which are well-known transcription
Figure 2 Association analysis between SNP genotypes for SSC8 and the percentages of: palmitic (A) and palmitoleic (B) acid in muscle
and palmitic (C) and palmitoleic (D) acid in backfat. ELOVL6 polymorphisms are included and labeled with a red circle. Positions in Mb are
relative to the Sscrofa 10.2 assembly of the pig genome. The vertical dashed line indicates the position of ELOVL6 gene and the horizontal dashed
line marks the chromosome-wide significance level (FDR-based q-value≤ 0.05).
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factors involved in the regulation of lipogenic genes
such as ELOVL6 [1,2,14,42]. Nevertheless, since several
SRE elements have been identified in the promoter re-
gion of ELOVL6, a site-specific chromatin immunopre-
cipitation (ChIP) approach is required to investigate
the capacity of SREBF1 to bind the specific methylated
SRE [45,46], as well as the effect of the methylation
level on SREBF1 binding. Regarding SP1 elements,
some studies have reported that variations in the SP1
binding site can reduce the methylation level of CpG
sites [47,48]. In our case, we found that the SP1 element
contains SNP ELOVL6:c-416C > T that was reported in
[2], which suggests a putative protective role against
methylation. In our data, this putative protective role
was also observed in the methylation levels of CpG5
(p-value = 1.13×10−03) and CpG4 motifs (p-value =
5.43×10−04) and a suggestive significant effect in the
CpG6 motif (p-value = 8×10−02) in adipose tissue. Never-
theless, functional studies are needed to investigate the
binding of SP1 to the ELOVL6 promoter and its role in
the control of the expression of ELOVL6.
Moreover, it has been shown that some transcription
factors are capable of regulating dynamic methylation
cycles that lead to rapid changes in the methylation
levels of the promoter of the regulated gene [49]. This
additional level of regulation may affect the regulation
of ELOVL6 expression in response to physiological
changes.
Figure 3 Characterization of the methylation patterns on the ELOVL6 gene promoter. (A) Schematic representation of the transcription
factor binding elements studied, together with the CpG-sites analyzed in the methylation study. (B) Plot showing the percentages of methylation
observed for each CpG-site in four porcine tissues: liver, backfat, muscle and spleen. Data represent means ± SEM. Values with different superscript
letters (a, b, c and d) indicate significant differences between groups (p-value < 0.05), as determined by a linear model in R.
Figure 4 Tissue-specific differences in ELOVL6 gene expression
among liver, adipose tissue, muscle and spleen. Gene expression
quantification was performed by real-time quantitative PCR (RT-qPCR),
according to the procedure described in [2]. Gene expression was
compared using the 2ΔCt data obtained from quantitative PCR
analyses. Data represent mean ± SEM.
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Role of the ELOVL6 promoter in the regulation of its
expression
Previous studies have shown that estrogen receptor
alpha (ERα) can cause rapid epigenetic modifications
that influence the regulation of gene expression [49,50].
Activation of ERα, by estradiol binding or phosphoryl-
ation of serine 118, modulates its three-dimensional sur-
face, causing a recruitment of coactivator complexes,
including DNA methyltransferases (DNMT) [49]. Hence,
to assess if ERα binding may be related to the different
methylation patterns detected in the promoter of ELOVL6
and, consequently to the expression of ELOVL6, a
computer-assisted identification of putative ERα binding
sites was performed using the LASAGNA-Search software
[51]. Interestingly, an estrogen response element (ERE)
was predicted at position −397 to −382, between the two
regions with different methylation patterns (Figure 3A).
The minimal consensus ERE sequence is a 13 bp palin-
dromic inverted repeat: 5'-GGTCAnnnTGACC-3' [52,53].
However, most estrogen-regulated genes contain imper-
fect ERE with variations of one or more nucleotides from
the consensus sequence. It has been reported that up to
two changes in the ERE consensus sequence may still
allow the binding of ER with the appropriate flanking se-
quences adjacent to the core [52]. In this way, although the
ERE sequence in the ELOVL6 promoter presents two base
changes from the consensus: 5’-GGGCTnnnTGACC-3’,
the immediate flanking sequences 5’-CAGGGCTnnnT-
GACCTG-3’ may be sufficient to retain ERE function
[52,53]. However, it should be noted that the consensus
ERE sequence of the porcine ELOVL6 promoter, contains
SNP ELOVL6:c.-394G > A, which constitutes a third muta-
tion in the half-site of the ERE palindrome that may pre-
vent the ER-ERE binding [52]. Interestingly, genotyping
data showed that ELOVL6:c.-394G > A and ELOVL6:c.-
533C > T SNPs are in complete linkage disequilibrium.
Statistical analyses showed a significant association
between SNP ELOVL6:c.-394G >A and CpG6 (p-value =
1.29×10−03), CpG5 (p-value = 6.92×10−04) and CpG4
(p-value = 7.41×10−04) in adipose tissue. Animals
homozygous for the ELOVL6:c.-394G allele showed a
higher methylation rate (Figure 5A). Accordingly, a
significant association was also observed between
ELOVL6 expression levels and SNP ELOVL6:c.-394G >A
(p-value = 3.25×10−02) (Figure 5B), as previously described
[2]. Based on RNA-Seq data [10], the ratio of differential
allelic expression between ELOVL6:c.-394G > A alleles
was found to be greater than 1.5 (A:G). Finally, a signifi-
cant association was observed between ELOVL6 expres-
sion and CpG5 (p-value = 3.47x10−02) and a suggestive
effect was found between ELOVL6 expression and CpG6
(p-value = 6.79×10−02).
Taken together, the results suggest a new mechanism
for the regulation of the expression of ELOVL6. The
hypothetical alteration of ERα binding by SNP ELOVL6:
c.-394G > A may be the main factor responsible for the
differential expression of ELOVL6 in adipose tissue. In
the methylated region that contains two SRE elements,
the SRE element between positions −460 and −449 con-
stitutes a clear candidate for methylation changes. Its
core binding site contains two CpG sites (CpG4 and
CpG5) (Figure 3A), whose methylation levels are associ-
ated with the ELOVL6:c.-394G > A genotype and ELOVL6
expression. In addition, previous studies in mouse have
shown that this SRE element has a relevant effect on
ELOVL6 expression [14]. Hence, inhibition of SREBF1
binding caused by the methylation of SRE elements in the
promoter of ELOVL6, in particular the SRE element lo-
cated between positions −460 and −449, is the most likely
mechanism responsible for the reduction of ELOVL6 ex-
pression. Previously, we showed that a reduced ELOVL6
expression is associated with an accumulation of palmitic
and palmitoleic acids in muscle and adipose tissue [2].
Thus, variation in ELOVL6 expression can modulate fatty
Figure 5 Effect of the ELOVL6:c.-394G > A polymorphism on ELOVL6 gene expression regulation. (A) Plot showing the percentage of
methylation observed for each CpG-site according to ELOVL6:c.-394G > A genotypes. (B) Plot showing ELOVL6 expression levels in backfat according
to ELOVL6:c.-394G > A genotypes. Data represents means ± SEM. Values with different superscript letter (a, b and c) indicate significant differences
between groups (p-value < 0.05) as determined by a linear model in R.
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acid composition in muscle and backfat and have im-
portant sensorial and technological consequences on
meat quality [54] and insulin sensitivity [7]. Our results
provide genetic evidence to support SNP ELOVL6:c.-
394G > A as the causal mutation of the QTL on SSC8
but additional investigations are necessary to validate its
effect on ERα binding. Furthermore, to our knowledge,
this is the first study that suggests a mechanism for the
regulation of ELOVL6 expression in pigs. Therefore,
based on the metabolic similarities between pigs and
humans [43], the regulatory mechanism described here
may be useful to improve knowledge on human lipid-
related diseases, such as obesity, diabetes or metabolic
syndrome.
Conclusions
In this paper, we describe the complete genetic structure
of porcine ELOVL6 gene and show that two different
isoforms are expressed in both liver and adipose tissue.
SNP ELOVL6:c.-533C > T was found to be more strongly
associated with the expression of ELOVL6 and with the
percentages of palmitic and palmitoleic acids in longissi-
mus dorsi and adipose tissue than the two genotyped
SNPs of the 3’UTR region. These results indicate that
the promoter region of ELOVL6 may be the main regu-
latory region involved in the variation of ELOVL6 ex-
pression in pigs. Interestingly, SNP ELOVL6:c.-394G > A,
which is in linkage disequilibrium with SNP ELOVL6:c.-
533C > T and is located in the only ERα binding site pre-
dicted in the promoter of ELOVL6, was found to be as-
sociated with variations in methylation patterns of the
region between −529 bp and −350 bp and with ELOVL6
expression. This region contains binding motifs for sev-
eral regulators of the ELOVL6 gene, which suggests that
epigenetic changes may have a central role in the regula-
tion of ELOVL6 expression. Hence, we suggest that SNP
ELOVL6:c.-394G > A is most likely responsible for the
differential expression of ELOVL6 and, consequently, for
the palmitic and palmitoleic acid contents in muscle and
backfat.
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